Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Potential interactions of the Orphan Drug Act and pharmacogenomics: a flood of orphan drugs and abuses?

× No keyword cloud information.

6 in total

1. Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products.

Authors: James W Dear; Pajaree Lilitkarntakul; David J Webb
Journal: Br J Clin Pharmacol Date: 2006-09 Impact factor: 4.335

2. Orphan drugs for rare diseases: is it time to revisit their special market access status?

Authors: Steven Simoens; David Cassiman; Marc Dooms; Eline Picavet
Journal: Drugs Date: 2012-07-30 Impact factor: 9.546

3. Pricing and reimbursement of orphan drugs: the need for more transparency.

Authors: Steven Simoens
Journal: Orphanet J Rare Dis Date: 2011-06-17 Impact factor: 4.123

4. The prevalence and cost of unapproved uses of top-selling orphan drugs.

Authors: Aaron S Kesselheim; Jessica A Myers; Daniel H Solomon; Wolfgang C Winkelmayer; Raisa Levin; Jerry Avorn
Journal: PLoS One Date: 2012-02-21 Impact factor: 3.240

5. What Is the Purpose of the Orphan Drug Act?

Authors: Matthew Herder
Journal: PLoS Med Date: 2017-01-03 Impact factor: 11.069

6. Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized Medicine.

Authors: Shannon Gibson; Hamid R Raziee; Trudo Lemmens
Journal: World Med Health Policy Date: 2015-03

6 in total